Literature DB >> 1340208

Expression of interleukin 5 by the CD4+CD45R0+ subset of human T cells.

W A Sewell1, J E Valentine, M A Cooley.   

Abstract

The expression of IL5 by CD4+CD45RA+, CD4+CD45R0+ and CD3+CD8+ subsets of human peripheral blood mononuclear cells was assessed. Interleukin 5 expression was detected by RNA extraction, reverse transcription and polymerase chain reaction. Populations of highly purified cells were obtained by a protocol of sequential plastic adherence, magnetic bead separation and flow cytometric cell sorting. IL5 was clearly expressed in the CD4+CD45R0+ subset from 3 to 48 hr after activation. The CD4+CD45RA+ and CD3+CD8+ subsets expressed very much less IL5. By contrast, IL2 expression was readily detected in all sorted populations. Thus, in activated CD4+ cells, IL5 was predominantly expressed in the CD4+CD45R0+ subset, a pattern of expression corresponding to that reported for a number of other cytokines, and differing from that of IL2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1340208     DOI: 10.3109/08977199209021541

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  5 in total

1.  IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression.

Authors:  S Till; S Durham; R Dickason; D Huston; J Bungre; S Walker; D Robinson; A B Kay; C Corrigan
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Cytokine expression by high-density human lymphocytes.

Authors:  W A Sewell; M F Berger; L J Skipsey; M A Cooley; H S Warren
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

3.  Inhibition of interleukin-5 gene expression by dexamethasone.

Authors:  F G Rolfe; J M Hughes; C L Armour; W A Sewell
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

4.  CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.

Authors:  D Adamthwaite; M A Cooley
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

5.  Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.

Authors:  Maria V Konopleva; Vera N Borisova; Maria V Sokolova; Tatyana A Semenenko; Anatoly P Suslov
Journal:  Vaccines (Basel)       Date:  2022-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.